002286 fundamentals

Key facts

Market capitalization‪2.97 B‬CNY
Founded1997
Employees (FY)‪1.22 K‬
CEOQiang Wang
Websiteblb-cn.com
About

Baolingbao Biology Co., Ltd. engages in the manufacture of all kinds functional sugar. Its products are categorized into prebiotics, sugar alcohols and new sugar, dietary fiber, starch and modified starch, starch sugar, and animal nutrition. The company was founded on October 16, 1997 and is headquartered in Dezhou, China.

Ownership
‪‪369.77 M‬‬
Free Float shares
‪‪316.71 M‬‬ (85.65%)
Closely held shares
‪‪53.06 M‬‬ (14.35%)
Free Float shares
‪‪316.71 M‬‬ (85.65%)
Closely held shares
‪‪53.06 M‬‬ (14.35%)
Capital structure
Market cap
‪‪2.97 B‬‬
Debt
‪‪363.70 M‬‬
Cash & equivalents
‪‪276.72 M‬‬
Enterprise value
‪‪3.06 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪2.97 B‬‬
Price to earning ratio (P/E)
27.26x
Price to sales ratio (P/S)
1.25x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
27.26x
Price to sales ratio (P/S)
1.25x
Valuation ratios
‪0.00‬
‪0.30‬
‪0.60‬
‪0.90‬
‪1.20‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪15.00‬
‪30.00‬
‪45.00‬
‪60.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪1.0%‬
‪2.6%‬
‪4.2%‬
‪5.8%‬
‪7.4%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪170.00 M‬‬
‪‪340.00 M‬‬
‪‪510.00 M‬‬
‪‪680.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪170.00 M‬‬
‪‪340.00 M‬‬
‪‪510.00 M‬‬
‪‪680.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪170.00 M‬‬
‪‪340.00 M‬‬
‪‪510.00 M‬‬
‪‪680.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Feed
Starch Sugar - Other Starch Sugar
Starch Sugar - Fructose Syrup
Functional Sugar - Oligosaccharides
Starch Sugar - Maltodextrin
Functional Sugar - Other Starch Sugar
By-products and Other
Functional Sugar - Sugar Alcohols
Other Business
By country
Period: 2023
China
Foreign

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q3 '21
‪0.00‬
‪‪210.00 M‬‬
‪‪420.00 M‬‬
‪‪630.00 M‬‬
‪‪840.00 M‬‬
Actual
Earnings
Next:Apr 25, 2025
2020
2021
2022
2023
2024
‪0.00‬
‪0.30‬
‪0.60‬
‪0.90‬
‪1.20‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
39.00%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
1.42%
Last payment
0.035
Last ex-date
Dec 10, 2024
Dividend history
‪0.40%‬
‪0.55%‬
‪0.70%‬
‪0.85%‬
‪1.00%‬
2019
2020
2021
2022
2023
‪0.00‬
‪0.02‬
‪0.04‬
‪0.06‬
‪0.08‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−150.00 M‬‬
‪0.00‬
‪‪150.00 M‬‬
‪‪300.00 M‬‬
‪‪450.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪500.00 M‬‬
‪‪1.00 B‬‬
‪‪1.50 B‬‬
‪‪2.00 B‬‬
Assets
Liabilities